Literature DB >> 21710229

Genotypic characterization of toxigenic group C and G streptococci isolated in Chennai, South India.

D Prabu1, Thangam Menon.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21710229     DOI： 10.1007/s12223-011-0050-0

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN： 0015-5632            Impact factor:   2.099


× No keyword cloud information.
  22 in total

1.  Surveillance of severe invasive group-G streptococcal infections and molecular typing of the isolates in Japan.

Authors:  T Ikebe; S Murayama; K Saitoh; S Yamai; R Suzuki; J Isobe; D Tanaka; C Katsukawa; A Tamaru; A Katayama; Y Fujinaga; K Hoashi; H Watanabe
Journal:  Epidemiol Infect       Date:  2004-01       Impact factor: 2.451

2.  speA and speC toxin genes among group A streptococcus isolates from school children in Chennai, India.

Authors:  Charmaine Lloyd; Thangam Menon
Journal:  J Med Microbiol       Date:  2007-11       Impact factor: 2.472

3.  Genetic features of clinical isolates of Streptococcus dysgalactiae subsp. equisimilis possessing Lancefield's group A antigen.

Authors:  Daisuke Tanaka; Junko Isobe; Masanori Watahiki; Yoshiyuki Nagai; Chihiro Katsukawa; Ryuji Kawahara; Miyoko Endoh; Rumi Okuno; Nanako Kumagai; Masakado Matsumoto; Yoshiro Morikawa; Tadayoshi Ikebe; Haruo Watanabe
Journal:  J Clin Microbiol       Date:  2008-02-27       Impact factor: 5.948

4.  Simplification of a locus-specific DNA typing method (Vir typing) for Streptococcus pyogenes.

Authors:  J Hartas; M Hibble; K S Sriprakash
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

5.  Toxic shock-like syndrome caused by non-group A beta-hemolytic streptococci.

Authors:  Y Hirose; K Yagi; H Honda; H Shibuya; E Okazaki
Journal:  Arch Intern Med       Date:  1997-09-08

Review 6.  Molecular basis of group A streptococcal virulence.

Authors:  A L Bisno; M O Brito; C M Collins
Journal:  Lancet Infect Dis       Date:  2003-04       Impact factor: 25.071

7.  Virulence profiling of Streptococcus dysgalactiae subspecies equisimilis isolated from infected humans reveals 2 distinct genetic lineages that do not segregate with their phenotypes or propensity to cause diseases.

Authors:  Mark R Davies; David J McMillan; Robert G Beiko; Vanessa Barroso; Robert Geffers; Kadaba S Sriprakash; Gursharan S Chhatwal
Journal:  Clin Infect Dis       Date:  2007-04-19       Impact factor: 9.079

Review 8.  What happened to the streptococci: overview of taxonomic and nomenclature changes.

Authors:  Richard Facklam
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

9.  Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden.

Authors:  Jessica Darenberg; Bogdan Luca-Harari; Aftab Jasir; Andreas Sandgren; Helena Pettersson; Claes Schalén; Mari Norgren; Victoria Romanus; Anna Norrby-Teglund; Birgitta Henriques Normark
Journal:  Clin Infect Dis       Date:  2007-07-10       Impact factor: 9.079

10.  Complete genome sequencing and analysis of a Lancefield group G Streptococcus dysgalactiae subsp. equisimilis strain causing streptococcal toxic shock syndrome (STSS).

Authors:  Yumi Shimomura; Kayo Okumura; Somay Yamagata Murayama; Junji Yagi; Kimiko Ubukata; Teruo Kirikae; Tohru Miyoshi-Akiyama
Journal:  BMC Genomics       Date:  2011-01-11       Impact factor: 3.969
View more
  2 in total

1.  Detection of Streptococcus pyogenes virulence genes in Streptococcus dysgalactiae subsp. equisimilis from Vellore, India.

Authors:  Anshu Babbar; Andreas Itzek; Dietmar H Pieper; D Patric Nitsche-Schmitz
Journal:  Folia Microbiol (Praha)       Date:  2018-03-12       Impact factor: 2.099

2.  Antibiotic susceptibilities, streptococcal pyrogenic exotoxin gene profiles among clinical isolates of group C or G Streptococcus dysgalactiae subsp. equisimilis & of group G S. anginosus group at a tertiary care centre.

Authors:  Bijayini Behera; Purva Mathur; Nidhi Bhardwaj; Neetu Jain; M C Misra; Arti Kapil; Sarman Singh
Journal:  Indian J Med Res       Date:  2014-03       Impact factor: 2.375
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.